Navigation Links
Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
Date:6/8/2008

Presentation Details Statistically Significant and Clinically Relevant Results for SB-509 in Development for Treatment of Diabetic Neuropathy

SAN FRANCISCO, June 8 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of encouraging Phase 1b clinical data from its ZFP Therapeutic(TM) program at the 68th Scientific Sessions of the American Diabetes Association (ADA). As disclosed in an oral presentation entitled, "Evidence of Neuroregeneration Using Vascular Endothelial Growth Factor (VEGF) Zinc Finger Protein Activator (SB-509) in Diabetic Neuropathy: A Chronic Degenerative Polyneuropathy," results of Sangamo's Phase 1b clinical trial (SB-509-401) demonstrated statistically significant improvements in measurements of nerve health and function in subjects with diabetic neuropathy.

"We are excited by the clinically relevant magnitude of improvements that were observed in measurements of nerve health and function in subjects with mild to moderate diabetic neuropathy over the six month trial period after a single administration of SB-509," commented the presenter, Mark Kipnes, M.D., lead investigator on the Phase 1 trial and an endocrinologist at the Diabetes and Glandular Disease Clinic, San Antonio, Texas. "Analgesics and antidepressants designed to control pain symptoms are the only drugs currently approved to treat this condition. In contrast, SB-509 is designed to address the actual nerve damage. These data demonstrate that SB-509 may have a neuroprotective and a neuroregenerative effect."

The data presented at ADA were collected from subjects with mild to moderate diabetic peripheral neuropathy enrolled in Sangamo's Phase 1b study of SB-509 (SB-509-401). Subjects recei
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
2. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
3. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
4. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
5. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
6. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
7. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
8. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
9. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
10. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
11. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... -- According to a new market research ... & Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, Polymeric, Polyurethane), by ... to 2020", published by MarketsandMarkets, the global Surgical Sealants ... by 2020, growing at a CAGR of 9.2% during ... Browse 119 market T ables and 29 ...
(Date:7/1/2015)... FT LAUDERDALE, Florida , July 1, 2015 /PRNewswire/ ... manufacturer and marketer of innovative medical devices for the treatment ... it prevailed in a final opposition appeal hearing in the ... 482 - STENT HAVING HELICAL ELEMENTS (,482). The ,482 patent ... and has been upheld as a valid patent in amended ...
(Date:7/1/2015)... , July 1, 2015  MEI Pharma, Inc. (Nasdaq: ... development of novel therapies for cancer, announced today that ... will present at the inaugural Cantor Fitzgerald Healthcare Conference on ... Le Parker Meridien in New York ... accessed at www.meipharma.com . A replay will be available ...
Breaking Medicine Technology:Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 2Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 3Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 4OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference 2
... Edwards, Inc. (Nasdaq: MSHL ), an oncology company ... metabolism, announced today that the first cohort of patients has ... the Company,s lead mitochondrial inhibitor drug candidate, in patients with ... enroll up to 24 patients in up to five cohorts ...
... Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today ... at the Jefferies 2012 Global Healthcare Conference in New York, NY. ... , Presentation date: Monday, June 4, 2012 , Presentation time: ... and 30-day archive of these presentations will be available at ...
Cached Medicine Technology:Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 2Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 3Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 4
(Date:7/1/2015)... ... July 01, 2015 , ... A healthy ... raised chickens and eggs. Eating organic foods and products can help limit the ... environmentally friendly than production chicken farming. Choosing home raised chickens and eggs that ...
(Date:7/1/2015)... ... 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. ... Symposium . Set for March 6th - 8th, the 2016 meeting will be held ... training and fundamentals of nasal surgery through the most modern advancements and updates in ...
(Date:7/1/2015)... ... ... Did you know that infertility in men is more common than couples ... Center of Texas (AFCT) would like to talk about some natural ways to increase ... be a “woman’s issue,” male fertility factors can play a role in about 40% ...
(Date:7/1/2015)... ... ... Convoy of Hope will partner with local businesses, churches, government agencies and ... Spring Lake Park High School. , During the celebration, Convoy of Hope and the ... services including free food, health services, family portraits, job services, a carnival and more. ...
(Date:7/1/2015)... ... ... is a disorder in which the normally straight vertical line of the spine curves to ... the population, or an estimated 6 to 9 million people. While it is found in ... and 15. Most types of scoliosis are more common in girls than in boys. When ...
Breaking Medicine News(10 mins):Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4
... CHICAGO, July 8 Last month the United ... Patient and Providers Act",(H.R. 6331). As a result, ... and other providers went into effect on July ... To view the Multimedia News Release, go ...
... Society of Hematology (ASH) is proud to announce the ... grant is given to training program directors to encourage ... , Thomas Abshire, MD, of Emory University, Donald ... David Sternberg, MD, PhD, of Mount Sinai School of ...
... soon on legislation that would cut $841 million,from ... 8 Seniors across,Pennsylvania are speaking out against ... being considered in the U.S. Senate. The,legislation (H.R. ... Advantage,program in Pennsylvania alone and severely cut back ...
... to vote soon on legislation that would cut ... WASHINGTON, July 8 Seniors across New,Hampshire ... Medicare Advantage,program in legislation being considered in the ... million from the Medicare Advantage program in,New Hampshire ...
... Levels Associated with Decreased Cancer Risk in Men with Peripheral ... participated in a randomized controlled trial in which their iron ... of cancer relative to men in the trial who did ... lower levels of iron in the blood may be associated ...
... Lower Health Care Costs, ... PITTSBURGH, July 8 The chief executives of ... the first,Pennsylvania Insurance Department public hearing about the combination ... for customers, health care,providers, and the communities the two ...
Cached Medicine News:Health News:Audio: Medicare Cuts Threaten Access to Health Care for Seniors 2Health News:Pennsylvania Seniors Speak Out Against Medicare Advantage Cuts 2Health News:New Hampshire Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Also in the July 8 JNCI 2Health News:Also in the July 8 JNCI 3Health News:Also in the July 8 JNCI 4Health News:Highmark and Independence Blue Cross CEOs Say Combination of Highmark and Independence Blue Cross will Provide $1 Billion in New Resources Over Six Years 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: